C1 esterase inhibitor [human] (C1INH-nf)

BIOLOGICAL5 trials

Sponsors

Shire

Conditions

Hereditary Angioedema

Phase 1

Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects

CompletedNCT00432510

ShireHereditary Angioedema

Start: 2006-10-09End: 2007-02-28Updated: 2021-06-03

Phase 3

C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

CompletedNCT00289211

ShireHereditary Angioedema

Start: 2005-03-14End: 2007-04-13Updated: 2021-06-11

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

CompletedNCT00438815

ShireHereditary Angioedema

Start: 2006-09-21End: 2009-03-31Updated: 2021-06-08

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

CompletedNCT00462709

ShireHereditary Angioedema

Start: 2006-06-27End: 2009-03-31Updated: 2021-06-08

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

CompletedNCT01005888

ShireHereditary Angioedema

Start: 2005-03-14End: 2007-08-22Updated: 2021-06-11

Related Papers

Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacks.

2019-03-0714 citations

Quality of life in patients with hereditary angioedema receiving therapy for routine prevention of attacks

Allergy and Asthma Proceedings2014-09-0160 citations

Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women.

2013-03-0115 citations

Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.

2011-11-2120 citations

Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.

2010-08-01280 citations